Role OF Geometric Mean in Estimation OF Differential Renal Function in DMSA Scintigraphy

Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05344807
Collaborator
(none)
100
1
6
16.5

Study Details

Study Description

Brief Summary

Renal scintigraphy is an imaging method that uses small amount of radioactive materials called radiotracers, a Gamma camera and a computer to evaluate kidney functions and its anatomy.

The relative renal function (RRF), expressed as a percent of total renal function, is important in the initial assessment and treatment of patients having renal diseases. RRF has traditionally been measured by radionuclide renal scintigraphies using different tracers for a long time . Different radiopharmaceuticals such as technetium-99m-diethylenetriaminepentaacetic acid (99mTc-DTPA), technetium-99m-dimercaptosuccinic acid (99mTc-DMSA), technetium-99m-mercaptoacetyltriglycine (99mTc-MAG3).

99mTc-DMSA is a static agent that is actively taken up by the proximal and distal renal tubular cells, directly from the peritubular vessels and accumulates in the renal cortex. Its binding level to protein in mammals is 90% which prevents significant glomerular filtration. DMSA renal scan images provide a good definition of the cortical outline, as well as they show the relative distribution of functional tissue.

Determination of the left to right dimercaptosuccinic acid (DMSA) uptake ratio is theoretically one of the easiest quantitative procedures in nuclear medicine. The quantification can be performed on the posterior view, with or without the lateral view for correction of kidney depth. The geometric mean can also be determined using both the anterior and the posterior views.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Renal DMSA Scintigraphy

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Role OF Geometric Mean in Estimation OF Differential Renal Function in DMSA Scintigraphy
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Outcome Measures

Primary Outcome Measures

  1. geometric mean of both anterior and posterior views of gamma camera [6 months]

    . We evaluate the discrepancy between function measured by conjugate anterior and posterior views in relationship to posterior view in DMSA scan .

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 70 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patients referred for renal DMSA scintigraphy

  • Patients aging 2 to 70 years

Exclusion Criteria:
  • Single kidney patients

  • Patients with a major uncontrollable medical illness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag University Hospital Sohag Egypt

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Shrouk Atef Abdelsalam, resident doctor at Nuclear medicine, Oncology department Sohag university hospital, Sohag University
ClinicalTrials.gov Identifier:
NCT05344807
Other Study ID Numbers:
  • Soh-Med-22-04-06
First Posted:
Apr 25, 2022
Last Update Posted:
Apr 25, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 25, 2022